世界のがんワクチン市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV03654)
◆英語タイトル:Global Cancer Vaccines Market Insights and Forecast to 2026
◆商品コード:QYR20NV03654
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:119
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートはがんワクチンの世界市場について調査・分析した資料です。種類別(予防がんワクチン、治療がんワクチン)の市場規模、用途別(子宮頸がん、前立腺がん、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別がんワクチンの競争状況、市場シェア
・世界のがんワクチン市場:種類別市場規模 2015年-2020年(予防がんワクチン、治療がんワクチン)
・世界のがんワクチン市場:種類別市場規模予測 2021年-2026年(予防がんワクチン、治療がんワクチン)
・世界のがんワクチン市場:用途別市場規模 2015年-2020年(子宮頸がん、前立腺がん、その他)
・世界のがんワクチン市場:用途別市場規模予測 2021年-2026年(子宮頸がん、前立腺がん、その他)
・北米のがんワクチン市場分析:米国、カナダ
・ヨーロッパのがんワクチン市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのがんワクチン市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のがんワクチン市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのがんワクチン市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Glaxosmithkline、Astellas Pharma、Merck、CSL Limited、Sanpower Group、Sanofi Pasteur、Pfizer、Serum Institute of India
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Cancer is the second leading cause of morbidity and mortality worldwide. Major cause of cancer is gene mutation and rarely due to inherited genes.
Factors such as increasing number of people with cancer, rising public awareness of vaccines, presence of promising late-stage pipeline candidates, and vendors’ patient-assistance programs also augment growth in the cancer vaccines market. Dendritic cells are cells taken from a patient’s immune system and treated with chemicals before being injected back into the patient. These cells produce an enhanced immune response against the malignant cells in the body and stimulate the other cells in the immune system to fight the cancerous cells.

Market Analysis and Insights: Global Cancer Vaccines Market
The global Cancer Vaccines market size is projected to reach US$ 5471.4 million by 2026, from US$ 4755.6 million in 2020, at a CAGR of 14.3%% during 2021-2026.

Global Cancer Vaccines Scope and Market Size
Cancer Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Cancer Vaccines market is segmented into
Preventive Cancer Vaccines
Therapeutic Cancer Vaccines

Segment by Application, the Cancer Vaccines market is segmented into
Cervical Cancer
Prostate Cancer
Others

Regional and Country-level Analysis
The Cancer Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Cancer Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Cancer Vaccines Market Share Analysis
Cancer Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cancer Vaccines business, the date to enter into the Cancer Vaccines market, Cancer Vaccines product introduction, recent developments, etc.

The major vendors covered:
Glaxosmithkline
Astellas Pharma
Merck
CSL Limited
Sanpower Group
Sanofi Pasteur
Pfizer
Serum Institute of India

【レポートの目次】

1 Study Coverage
1.1 Cancer Vaccines Product Introduction
1.2 Market Segments
1.3 Key Cancer Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Cancer Vaccines Market Size Growth Rate by Type
1.4.2 Preventive Cancer Vaccines
1.4.3 Therapeutic Cancer Vaccines
1.5 Market by Application
1.5.1 Global Cancer Vaccines Market Size Growth Rate by Application
1.5.2 Cervical Cancer
1.5.3 Prostate Cancer
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Cancer Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Cancer Vaccines Revenue 2015-2026
2.1.2 Global Cancer Vaccines Sales 2015-2026
2.2 Global Cancer Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Cancer Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Cancer Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Cancer Vaccines Competitor Landscape by Players
3.1 Cancer Vaccines Sales by Manufacturers
3.1.1 Cancer Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Cancer Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Cancer Vaccines Revenue by Manufacturers
3.2.1 Cancer Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Cancer Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Cancer Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Cancer Vaccines Revenue in 2019
3.2.5 Global Cancer Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Cancer Vaccines Price by Manufacturers
3.4 Cancer Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Cancer Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cancer Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Cancer Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Cancer Vaccines Market Size by Type (2015-2020)
4.1.1 Global Cancer Vaccines Sales by Type (2015-2020)
4.1.2 Global Cancer Vaccines Revenue by Type (2015-2020)
4.1.3 Cancer Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Cancer Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Cancer Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Cancer Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Cancer Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Cancer Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Cancer Vaccines Market Size by Application (2015-2020)
5.1.1 Global Cancer Vaccines Sales by Application (2015-2020)
5.1.2 Global Cancer Vaccines Revenue by Application (2015-2020)
5.1.3 Cancer Vaccines Price by Application (2015-2020)
5.2 Cancer Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Cancer Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Cancer Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Cancer Vaccines Price Forecast by Application (2021-2026)

6 North America
6.1 North America Cancer Vaccines by Country
6.1.1 North America Cancer Vaccines Sales by Country
6.1.2 North America Cancer Vaccines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Cancer Vaccines Market Facts & Figures by Type
6.3 North America Cancer Vaccines Market Facts & Figures by Application

7 Europe
7.1 Europe Cancer Vaccines by Country
7.1.1 Europe Cancer Vaccines Sales by Country
7.1.2 Europe Cancer Vaccines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Cancer Vaccines Market Facts & Figures by Type
7.3 Europe Cancer Vaccines Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Cancer Vaccines by Region
8.1.1 Asia Pacific Cancer Vaccines Sales by Region
8.1.2 Asia Pacific Cancer Vaccines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Cancer Vaccines Market Facts & Figures by Type
8.3 Asia Pacific Cancer Vaccines Market Facts & Figures by Application

9 Latin America
9.1 Latin America Cancer Vaccines by Country
9.1.1 Latin America Cancer Vaccines Sales by Country
9.1.2 Latin America Cancer Vaccines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Cancer Vaccines Market Facts & Figures by Type
9.3 Central & South America Cancer Vaccines Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Cancer Vaccines by Country
10.1.1 Middle East and Africa Cancer Vaccines Sales by Country
10.1.2 Middle East and Africa Cancer Vaccines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Cancer Vaccines Market Facts & Figures by Type
10.3 Middle East and Africa Cancer Vaccines Market Facts & Figures by Application

11 Company Profiles
11.1 Glaxosmithkline
11.1.1 Glaxosmithkline Corporation Information
11.1.2 Glaxosmithkline Description and Business Overview
11.1.3 Glaxosmithkline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Glaxosmithkline Cancer Vaccines Products Offered
11.1.5 Glaxosmithkline Related Developments
11.2 Astellas Pharma
11.2.1 Astellas Pharma Corporation Information
11.2.2 Astellas Pharma Description and Business Overview
11.2.3 Astellas Pharma Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Astellas Pharma Cancer Vaccines Products Offered
11.2.5 Astellas Pharma Related Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Description and Business Overview
11.3.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merck Cancer Vaccines Products Offered
11.3.5 Merck Related Developments
11.4 CSL Limited
11.4.1 CSL Limited Corporation Information
11.4.2 CSL Limited Description and Business Overview
11.4.3 CSL Limited Sales, Revenue and Gross Margin (2015-2020)
11.4.4 CSL Limited Cancer Vaccines Products Offered
11.4.5 CSL Limited Related Developments
11.5 Sanpower Group
11.5.1 Sanpower Group Corporation Information
11.5.2 Sanpower Group Description and Business Overview
11.5.3 Sanpower Group Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sanpower Group Cancer Vaccines Products Offered
11.5.5 Sanpower Group Related Developments
11.6 Sanofi Pasteur
11.6.1 Sanofi Pasteur Corporation Information
11.6.2 Sanofi Pasteur Description and Business Overview
11.6.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Sanofi Pasteur Cancer Vaccines Products Offered
11.6.5 Sanofi Pasteur Related Developments
11.7 Pfizer
11.7.1 Pfizer Corporation Information
11.7.2 Pfizer Description and Business Overview
11.7.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Pfizer Cancer Vaccines Products Offered
11.7.5 Pfizer Related Developments
11.8 Serum Institute of India
11.8.1 Serum Institute of India Corporation Information
11.8.2 Serum Institute of India Description and Business Overview
11.8.3 Serum Institute of India Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Serum Institute of India Cancer Vaccines Products Offered
11.8.5 Serum Institute of India Related Developments
11.1 Glaxosmithkline
11.1.1 Glaxosmithkline Corporation Information
11.1.2 Glaxosmithkline Description and Business Overview
11.1.3 Glaxosmithkline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Glaxosmithkline Cancer Vaccines Products Offered
11.1.5 Glaxosmithkline Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Cancer Vaccines Market Estimates and Projections by Region
12.1.1 Global Cancer Vaccines Sales Forecast by Regions 2021-2026
12.1.2 Global Cancer Vaccines Revenue Forecast by Regions 2021-2026
12.2 North America Cancer Vaccines Market Size Forecast (2021-2026)
12.2.1 North America: Cancer Vaccines Sales Forecast (2021-2026)
12.2.2 North America: Cancer Vaccines Revenue Forecast (2021-2026)
12.2.3 North America: Cancer Vaccines Market Size Forecast by Country (2021-2026)
12.3 Europe Cancer Vaccines Market Size Forecast (2021-2026)
12.3.1 Europe: Cancer Vaccines Sales Forecast (2021-2026)
12.3.2 Europe: Cancer Vaccines Revenue Forecast (2021-2026)
12.3.3 Europe: Cancer Vaccines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Cancer Vaccines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Cancer Vaccines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Cancer Vaccines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Cancer Vaccines Market Size Forecast by Region (2021-2026)
12.5 Latin America Cancer Vaccines Market Size Forecast (2021-2026)
12.5.1 Latin America: Cancer Vaccines Sales Forecast (2021-2026)
12.5.2 Latin America: Cancer Vaccines Revenue Forecast (2021-2026)
12.5.3 Latin America: Cancer Vaccines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Cancer Vaccines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Cancer Vaccines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Cancer Vaccines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Cancer Vaccines Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Cancer Vaccines Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cancer Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

...

【掲載企業】

Glaxosmithkline、Astellas Pharma、Merck、CSL Limited、Sanpower Group、Sanofi Pasteur、Pfizer、Serum Institute of India

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のがんワクチン市場2026:インサイト・予測(Global Cancer Vaccines Market Insights and Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。